Patients with alopecia areata have a significantly increased risk of developing psychiatric and autoimmune diseases both before and after diagnosis, highlighting the importance of comprehensive care ...

Higher risk for incident comorbidities also seen compared with matched controls without alopecia. HealthDay News — Patients with alopecia areata have a higher prevalence of autoimmune and psychiatric ...

Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects ...

Students at Burning Springs Elementary School are wearing blue every Wednesday in September to support a 10-year-old ...

Researchers have identified a link between psoriasis and the autoimmune diseases hypothyroidism and alopecia areata. Recent findings from a single tertiary care center show that nearly three-quarters ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical-stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, ...

Patients with new-onset alopecia areata (AA) had a significantly higher 10-year risk of developing multiple immune-mediated inflammatory diseases (IMIDs), a study reports. "This analysis demonstrates ...

DAYTON, Ohio (WDTN) — We are coming to the end of festival and race season here in the Miami Valley, and one local group just celebrated a milestone. The Bare Hair 5K just held its 10th annual race, ...

WWE star Thea Hail has revealed that she has been diagnosed with alopecia areata, an autoimmune condition in which the immune system mistakenly attacks hair fo ...

Alopecia areata universalis is an autoimmune disease that affects nearly 7 million Americans.

Patients with alopecia areata (AA) had a higher prevalence of several psychiatric and autoimmune comorbidities at baseline and were at greater risk of developing those comorbidities after diagnosis.

Patients with alopecia areata had a higher prevalence of autoimmune and psychiatric comorbidities at diagnosis and an increased risk of new onset of these comorbidities after their diagnosis, ...